These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21903346)

  • 1. Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A.
    Mannava S; Plate JF; Stone AV; Smith TL; Smith BP; Koman LA; Tuohy CJ
    J Hand Surg Am; 2011 Oct; 36(10):1708-10. PubMed ID: 21903346
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of botulinum toxin in vasospastic disorders of the hand.
    Neumeister MW
    Hand Clin; 2015 Feb; 31(1):23-37. PubMed ID: 25455354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of palmar hyperhidrosis with botulinum neurotoxin a.
    Mannava S; Mannava KA; Nazir OF; Plate JF; Smith BP; Koman LA; Tuohy CJ
    J Hand Surg Am; 2013 Feb; 38(2):398-400. PubMed ID: 23267759
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
    De Laet K; Wyndaele JJ
    Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cosmetic uses of botulinum neurotoxin type A: an overview.
    Blitzer A; Binder WJ
    Arch Facial Plast Surg; 2002; 4(4):214-20. PubMed ID: 12437425
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of Raynaud's digital ulcer with interdigital Botulinum toxin A injection.
    Navarro EP; Cañas CA; Tobón GJ
    Rheumatology (Oxford); 2016 Jul; 55(7):1216. PubMed ID: 27155203
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary: Efficacy and safety of a novel botulinum toxin topical gel.
    West TB
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2119-20. PubMed ID: 21244565
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis.
    Khan S; Game X; Kalsi V; Gonzales G; Panicker J; Elneil S; Apostolidis A; Hamid R; Dasgupta P; Kessler TM; Fowler CJ
    J Urol; 2011 Apr; 185(4):1344-9. PubMed ID: 21334639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of botulinum toxin for the treatment of children with chronic anal fissure.
    Khout H; Kadi N
    Eur J Pediatr Surg; 2010 Nov; 20(6):412. PubMed ID: 21181607
    [No Abstract]   [Full Text] [Related]  

  • 10. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
    Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B
    Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of botulinum toxin.
    American Society of Plastic Surgeons, Executive Committee
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):4S-5S. PubMed ID: 14510021
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of a transparent dressing in the treatment of axillary hyperhidrosis with botulinum toxin type A.
    Galán-Gutiérrez M; Garnacho-Saucedo G; Salido-Vallejo R; Vélez Garcia-Nieto A; Moreno-Giménez JC
    J Am Acad Dermatol; 2010 Dec; 63(6):e111-2. PubMed ID: 21093655
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections.
    Pascali MP; Mosiello G; Boldrini R; Salsano ML; Castelli E; De Gennaro M
    J Urol; 2011 Jun; 185(6 Suppl):2552-7. PubMed ID: 21527192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive treatment of Raynaud phenomenon: the role of botulinum type A.
    Neumeister MW; Webb KN; Romanelli M
    Hand Clin; 2014 Feb; 30(1):17-24. PubMed ID: 24286738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Input from a specialized nurse consultation in the management of detrusor overactivity treated with intradetrusor injections of botulinum toxin in urology department. Pilot study].
    Le Gal S; Safsaf A; Galliot I; Catovic B; Grise P
    Prog Urol; 2010 Sep; 20(8):584-9. PubMed ID: 20832036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type a headache treatment and entrapment of the supratrochlear nerve.
    Saers SJ; de Ru JA
    Arch Dermatol; 2010 Nov; 146(11):1310-1; author reply 1311. PubMed ID: 21079079
    [No Abstract]   [Full Text] [Related]  

  • 17. A simplified technique for botulinum toxin injections in children with neurogenic bladder.
    Pascali MP; Mosiello G; Marciano A; Capitanucci ML; Zaccara AM; De Gennaro M
    J Urol; 2011 Jun; 185(6 Suppl):2558-62. PubMed ID: 21527204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin-A is an effective and safe treatment for chronic migraine.
    de Ru JA
    Headache; 2013; 53(7):1165-7. PubMed ID: 23865917
    [No Abstract]   [Full Text] [Related]  

  • 19. Skin cooling provides minimal relief of patient discomfort during periocular botulinum toxin type A injection.
    Beer KR; Wilson F
    Dermatol Surg; 2011 Jun; 37(6):870-2. PubMed ID: 21605254
    [No Abstract]   [Full Text] [Related]  

  • 20. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
    Kapoor R; Shome D; Jain V; Dikshit R
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.